Melanocortin-4 receptor binding compounds and methods of use thereof
Details for Australian Patent Application No. 2004320025 (hide)
International Classifications
Event Publications
19 January 2006 Application Open to Public Inspection
Published as AU-A-2004320025
19 January 2006 PCT application entered the National Phase
29 May 2008 Alteration of Name
The name of the applicant has been altered to Ore Pharmaceuticals Inc. 2005
11 December 2008 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the Name Ore Pharmaceuticals Inc., Application No. 2004320025, under INID (43), correct the date to 22 December 2005
19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004320026-Safeguard cap and injection needle with a safeguard cap
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser